Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination
暂无分享，去创建一个
F. Meloni | M. Carta | M. Campagna | A. Perra | M. Conti | G. Orrù | G. Fenu | S. D. Del Giacco | D. Firinu | R. Littera | F. Coghe | L. Chessa | G. Costanzo | Selene Cipri | Francesca Sedda | Michela Miglianti | Marta Secci | Gianmario Usai | R. Cappai